Dechra Pharmaceuticals PLC
DCHPF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,037,261 | $3,015,011 | $3,471,768 | $5,430,118 |
| - Cash | $74,400 | $87,900 | $120,900 | $123,700 |
| + Debt | $504,500 | $511,200 | $329,100 | $316,800 |
| Enterprise Value | $4,467,361 | $3,438,311 | $3,679,968 | $5,623,218 |
| Revenue | $384,100 | $377,400 | $349,400 | $332,400 |
| % Growth | 1.8% | 8% | 5.1% | – |
| Gross Profit | $211,100 | $218,500 | $196,100 | $188,700 |
| % Margin | 55% | 57.9% | 56.1% | 56.8% |
| EBITDA | -$15,900 | $47,200 | $61,100 | $64,800 |
| % Margin | -4.1% | 12.5% | 17.5% | 19.5% |
| Net Income | -$50,500 | $22,600 | $17,500 | $40,700 |
| % Margin | -13.1% | 6% | 5% | 12.2% |
| EPS Diluted | -0.44 | 0.199 | 0.16 | 0.38 |
| % Growth | -321.6% | 23.8% | -57.8% | – |
| Operating Cash Flow | $12,100 | $51,500 | $34,800 | $88,100 |
| Capital Expenditures | -$12,300 | -$10,500 | -$9,100 | -$11,200 |
| Free Cash Flow | -$200 | $41,000 | $25,700 | $76,900 |